Skip to main content
Livermore
Livermore
ZHEN

Palvella Therapeutics, Inc.

PVLA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001583648

In the last 90 days, Palvella Therapeutics, Inc. insiders filed 0 open-market purchases and 5 sales; 196 institutions reported holding it in 13F filings for Q2 2026, worth $2.15B in total; no superinvestor holds it.

Q2 2026 vs. Q1 2026

How the institutions holding Palvella Therapeutics, Inc. changed between Q1 2026 and Q2 2026.

All holders in Q2 2026All holders in Q1 2026

13F holders of PVLA: Q1 2026 compared with Q2 2026
MeasureQ1 2026Of which not filed for Q2 2026Q2 2026Change
Holders1802196+18
Shares13.2M3.63K14.1M+904.8K (+6.9%)
Value$1.64B$454.3K$2.15B+$508.7M (+31.1%)

2 institutions that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so the changes leave them out.

New holders (37)

Institutions that held Palvella Therapeutics, Inc. at the end of Q2 2026 but not at the end of Q1 2026.

Institutions new to PVLA in Q2 2026
InstitutionSharesValue% of portfolio
Bellevue Group AG155,000$23.7M0.50%
HSBC Holdings PLC50,001$7.64M0.00%
Silvercrest Asset Management Group LLC39,865$6.09M0.04%
Mutual of America Capital Management LLC31,318$4.79M0.05%
ACT Capital Management, LLC22,500$3.44M2.25%
Capricorn Fund Managers Ltd14,088$2.15M0.17%
Oak Ridge Investments LLC12,038$1.84M0.10%
Martingale Asset Management L P8,406$1.28M0.03%
Tudor Investment Corp Et Al7,906$1.21M0.00%
Penn Capital Management Co Inc5,506$841.4K0.05%
Mitsubishi UFJ Asset Management (UK) Ltd.5,500$841.0K0.39%
Jupiter Topco LLC3,600$550.5K0.00%
Marshall Wace, LLP2,852$435.8K0.00%
AQR Capital Management LLC2,316$353.9K0.00%
DnB Asset Management AS2,244$342.9K0.00%
Brevan Howard Capital Management LP2,180$333.1K0.00%
Prudential Financial Inc1,755$268.2K0.00%
Quantinno Capital Management LP1,517$231.8K0.00%
ProShare Advisors LLC1,434$219.1K0.00%
Pictet Asset Management Holding SA1,331$203.4K0.00%
Fulcrum Asset Management LLP1,126$174.3K0.02%
State of Wyoming879$134.3K0.01%
Quantbot Technologies LP462$70.6K0.00%
Kemnay Advisory Services Inc.374$57.2K0.01%
Northwestern Mutual Wealth Management Co229$35.0K0.00%
Bayforest Capital Ltd208$31.8K0.03%
Pacer Advisors, Inc.190$29.0K0.00%
BNP PARIBAS ASSET MANAGEMENT Holding S.A.168$25.7K0.00%
Nykredit A/S139$21.2K0.00%
Eastern Bank52$7.95K0.00%
Global Retirement Partners, LLC31$4.74K0.00%
Quarry LP23$3.52K0.00%
SRS Capital Advisors, Inc.19$2.90K0.00%
CoreCap Advisors, LLC11$1.68K0.00%
Silver Grove Financial Group, Inc.7$1.07K0.00%
Essential Partners LLC1$1530.00%
Newbridge Financial Services Group, Inc.1$1150.00%

Sold out (19)

Institutions that held Palvella Therapeutics, Inc. at the end of Q1 2026 and filed for Q2 2026 without it.

Institutions that sold out of PVLA in Q2 2026
InstitutionShares, Q1 2026Value, Q1 2026
Artisan Partners Limited Partnership193,796$24.2M
Point72 Asset Management, L.P.88,160$11.0M
Ikarian Capital, LLC64,626$8.06M
Samsara BioCapital, LLC38,432$4.79M
BlueCrest Capital Management Ltd20,000$2.49M
Boothbay Fund Management, LLC18,962$2.36M
Quadrature Capital Ltd8,232$1.03M
Virtu Financial LLC7,726$963.0K
Aquatic Capital Management LLC6,652$829.2K
HighVista Strategies LLC5,903$735.8K
Prosight Management, LP5,000$623.3K
Hudson Bay Capital Management LP2,140$266.8K
Mangrove Partners1,791$223.2K
Dark Forest Capital Management LP1,606$200.2K
Caitong International Asset Management Co., Ltd180$22.4K
Quadrant Capital Group LLC10$1.25K
Twin Peaks Wealth Advisors, LLC7$873
Ameritas Advisory Services, LLC1$125
Swiss Life Asset Management Ltd471–

Not filed for Q2 2026 yet (2)

Institutions that held Palvella Therapeutics, Inc. at the end of Q1 2026 and haven't filed a 13F for Q2 2026. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding PVLA in Q1 2026 that haven't filed for Q2 2026
InstitutionShares, Q1 2026Value, Q1 2026
Janus Henderson Group PLC3,600$449.9K
CWM, LLC35$4.36K